Alfacalcidol

The AOK Northeast The health insurance company in Germany from Europe region has released this tender for Alfacalcidol The subject of this publication is the conclusion of agreements in accordance with Section 130a Paragraph 8 SGB V on various active ingredients combinations of active ingredients as part of a so-called open house procedure Subject to uniform contractual conditions and a uniform access procedure all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient combination of active ingredients mentioned After registering interested pharmaceutical companies can download the order documents participation documents and contract at https www dtvp de Satellite notice CXP4Y6MMRJK The email address specified in the Client section for the purpose of unrestricted and complete free access to the order documents is no longer valid Information can only be obtained by registering on the DTVP procurement platform under the communication tab Information and answers provided by other bodies are not binding The prerequisite for concluding a contract is that the interested pharmaceutical company submits the required procedural documents completely completed and signed Any pharmaceutical company that meets the participation requirements and documents this by signing the declarations and the discount agreement can join the discount agreement NEW The option of a qualified electronic signature is now also offered For further information please refer to the Procedural Information form There is no exclusivity Joining or concluding a contract can take place at any time and under the same conditions Individual contract negotiations will not be carried out The contract can only begin on the first of each month The earliest contract start date is February 1st 2026 Based on this the contract term is a maximum of 24 months The contract ends on January 31 2028 at the latest regardless of the date the contract was concluded The deadline for submitting offers is always the 5th of the previous month Example contract start February 1st 2026 deadline for submitting the offer January 5th 2026 Should AOK Nordost award an exclusive contract for the active ingredient combination of active ingredients during an open procedure during the contract term the contractual provisions concluded in this publication apply This publication does not involve the award of a public contract within the meaning of the Procurement Coordination Directive 2014 24 EU of the European Parliament and of the Council or public procurement law In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts publication will take place in the supplement to the Official Journal of the European Union In the absence of a corresponding publication form this form of contract notice is used The resulting conceptual specifications such as the procedural designation open procedure are solely due to the use of this announcement form and the publication platform This does not entail any further meaning in particular subjection to procurement regulations unless they are required for legal reasons The orders awarded will only be announced under the following link https www aok de gp arzneimittel verkaufvertraege-background with tender notice no. 251127_OH FAM NOST_91_GW published on 01 Dec 2025. The tender is due to expire on 06 Dec 2027. This tender is sourced from Vergabe and is eligible for suppliers interested in Pharmaceutical products. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 10367860.